Chovel-SellaABen TovALahavE. Incidence of rash after amoxicillin treatment in children with infectious mononucleosis. Pediatrics. 2013;131:e1424-e1427.
3.
OdomR. Andrew’s Diseases of the Skin. 9th ed.Philadelphia, PA: WB Saunders; 2000:136-138.
4.
PowersSCarter-BeardG. Visual diagnosis: rash, eye pain, lesions in an adolescent. Pediatr Rev. 2010;31(12):e86-e90.
5.
RoujeauJCKellyJPNaldiL. Medication use and the risk of Stevens–Johnson syndrome or toxic epidermal necrolysis. N Engl J Med. 1995;333:1600-1608.
6.
TayYKHuffJCWestonWL. Mycoplasma pneumoniae infection is associated with Stevens–Johnson syndrome, not erythema multiforme (von Hebra). J Am Acad Dermatol. 1996;35:757-760.
7.
KhaliliBBahnaSL. Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis. Ann Allergy Asthma Immunol. 2006;97:272-281.
8.
Garcia-DovalILeCleachLBocquetHOteroXRoujeauJ. Toxic epidermal necrolysis and Stevens–Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death?Arch Dermatol. 2000;136:323-327.
9.
GhislainPDRoujeauJC. Treatment of severe drug reactions: Stevens–Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol Online J. 2002;8(1):5.
10.
HalebianPHCorderVJMaddenMRFinklesteinJLShiresGT. Improved bum center survival of patients with toxic epidermal necrolysis managed without corticosteroids. Ann Surg. 1986;204:503-512.
11.
BachotNRevuzJRoujeauJ. Intravenous immunoglobulin treatment for Stevens–Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression. Arch Dermatol. 2003;139:33-36.
12.
SchneckJFagotJPSekulaPSassolasBRoujeauJCMockenhauptM. Effects of treatments on the mortality of Stevens–Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR study. J Am Acad Dermatol. 2008;58:33-40.
13.
PrinsCVittorioCPadillaRS. Effect of high-dose intravenous immunoglobulin therapy in Stevens–Johnson syndrome: a retrospective, multicenter study. Dermatology. 2003;207:96-99.
